Global /Sweden /Healthcare /Medical Devices /EPIS-B
chevron_leftBack
Episurf Medical AB (publ) logo

Episurf Medical AB (publ)

EPIS-B
STO: EPIS-B Delayed
0.0620SEK -2.1%
0.0065 USD
As of 6 June 2026, Episurf Medical AB (publ) has a market cap of $60.3M USD, ranking #29218 globally and #390 in Sweden. It ranks #2650 in the Healthcare sector, and #546 in the Medical Devices industry.
Global Rank
29218
Country Rank
390
Sector Rank
2650
Industry Rank
546
Key Stats
Market Cap
$60.3MUSD
565.22M SEK
Enterprise Value
$59.43MUSD
563.02M SEK
Revenue (TTM)
$2.16MUSD
20.2M SEK
EBITDA (TTM)
-$5.84MUSD
-55.3M SEK
Net Income (TTM)
-$6.21MUSD
-58.2M SEK
EBITDA Margin
-274%
Profit Margin
-288%
PS Ratio
28.0
PB Ratio
11.9
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Jens Andersson open_in_new
Employees
19
Founded
2008
Website
episurf.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-2.1% 3.2% 4.9% 51% 96% -47%

News

Loading...

Markets

Exchange Ticker Price
Nasdaq Stockholm
MIC: XSTO
PRIMARY
EPIS-B
Episurf Medical AB Class B
ISIN: SE0003491562
Shares Out.:
4.385B1 Shares Float: 4.357B2
TV:
SA:
YF:
GF:
BA:
MS:
0.0620 SEK
London Stock Exchange
MIC: XLON
0QUT
ISIN: SE0003491562
TV:
SA:
YF:
GF:
BA:
MS:
0.1000 SEK
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Episurf Medical AB (publ)

Episurf Medical AB (publ), a medical device company, designs and manufactures implants and surgical instruments in Germany, Sweden, rest of Europe, the United States, and internationally. It provides Episealer Knee for repairing focal cartilage and bone defects to reduce pain and increase mobility in the patient’s knee joint; Episealer implant, which is designed to fit anatomy and size of the lesion; Episealer toolkit; and Episealer Patellofemoral System, a system to treat osteoarthritis limited to the patellofemoral part of the knee joint. The company also offers Epioscopy to identify and visualize femoral knee joint cartilage and bone lesions, and tibia, as well as defects on the cruciate ligaments and menisci; Epiguide, a surgical drill guide; and µiFidelity, a web platform for order management, communication, personalized design, and surgical pre-planning. In addition, it is developing Episealer MTP implant, an implant for the MTP joint of the big toe in the foot. Further, the company offers Talus Osteotomy Guide (TOG) that is designed to fit on the patient’s distal tibia using CT and MRI images; MRI protocol to ensure correct damage assessment, 3D visualization, and device design; and Damage Marking Report (DMR) that enables 3D visualization of damage in the joint surface and underlaying bone defects, as well as other findings relevant when selecting the right treatment for the patient. The company was formerly known as Diamorph Medtech AB and changed its name to Episurf Medical AB (publ) in 2010. Episurf Medical AB (publ) was incorporated in 2008 and is based in Stockholm, Sweden.

Similar Companies

Industry: Medical Devices (Sweden)
Name
Market Cap diff.
PE
GETI-B
$5.59B
52.4B SEK
9K%
22.2
S
SCIB
$4.85B
45.5B SEK
8K%
-
EKTA-B
$2.23B
20.86B SEK
4K%
-
$1.59B
14.87B SEK
3K%
-
$1.53B
14.32B SEK
2K%
78.5
$907.38M
8.5B SEK
1K%
115.1
Industry: Medical Devices (Global)
Name
Market Cap diff.
PE
$173.27B
287K%
25.8
$160.73B
266K%
56.7
$159.07B
264K%
25.6
DHR
$126.55B
210K%
34.7
SYK
$120.69B
200K%
38.3
MDT
$101.9B
169K%
22.2
chevron_leftBack